Voyageur Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Voyageur Pharmaceuticals has a total shareholder equity of CA$1.6M and total debt of CA$40.0K, which brings its debt-to-equity ratio to 2.5%. Its total assets and total liabilities are CA$2.6M and CA$985.2K respectively.
Key information
2.5%
Debt to equity ratio
CA$40.00k
Debt
Interest coverage ratio | n/a |
Cash | CA$253.25k |
Equity | CA$1.58m |
Total liabilities | CA$985.22k |
Total assets | CA$2.56m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: VM's short term assets (CA$449.4K) do not cover its short term liabilities (CA$931.2K).
Long Term Liabilities: VM's short term assets (CA$449.4K) exceed its long term liabilities (CA$54.0K).
Debt to Equity History and Analysis
Debt Level: VM has more cash than its total debt.
Reducing Debt: VM's debt to equity ratio has reduced from 37.4% to 2.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VM has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: VM is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.